Crescent Capital BDC, Inc. - Common Stock (CCAP)

Add-on financings now make up half of Crescent's deal count, a shift that shapes how the firm is working through a slow buyout market.

Buyback and new joint venture unveiled as watch list ticks higher.

Crescent Capital BDC (NASDAQ:CCAP) reported a slight increase in third-quarter investment income and announced plans to buy back shares and form a joint venture as it works to reduce leverage. Net investment income rose to $0.37 per share from $0.36 in the previous quarter, exceeding the company’s

Crescent Capital BDC (NASDAQ:CCAP) reported second-quarter net investment income of $0.36 per share, exceeding its $0.34 per-share base dividend but declining from $0.38 per share in the prior quarter excluding a one-time incentive-fee waiver. The business development company’s net asset value fell

CCAP Q1 2026 Earnings Call Transcript

Crescent Capital BDC (NASDAQ:CCAP) reported a more difficult first quarter as higher non-accruals, lower base rates and broader credit-market volatility weighed on earnings and net asset value, prompting management to lower fees and reset the company’s base dividend. Chief Executive Officer Jason B

Crescent Capital BDC (CCAP) Earnings Transcript

Crescent Capital BDC (CCAP) Earnings Transcript

Crescent Capital BDC reported mixed Q3 2025 results, with EPS beating estimates but revenue falling short. The stock showed a muted reaction.

Crescent Capital BDC (CCAP) reports Q2 2025 earnings with $0.46 NII per share, slightly below estimates. Declares $0.42 dividend and $20M buyback amid stable portfolio performance.

CCAP stock results show that Crescent Capital BDC beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.